Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GEWIRTZ, A. M")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 51

  • Page / 3
Export

Selection :

  • and

Perturbing gene expression with oligodeoxynucleotides : Research and potential therapeutic applicationsGEWIRTZ, A. M.The Mount Sinai journal of medicine. 1996, Vol 63, Num 5-6, pp 372-380, issn 0027-2507Article

Human megakaryocytopoiesisGEWIRTZ, A. M.Seminars in hematology. 1986, Vol 23, Num 1, pp 27-42, issn 0037-1963Article

Developing oligonucleotide therapeutics for human leukemiaGEWIRTZ, A. M.Anti-cancer drug design. 1997, Vol 12, Num 5, pp 341-358, issn 0266-9536Article

Transitory hypomegakaryocytic thrombocytopenia: aetiological association with ethanol abuse and implications regarding regulation of human megakaryocytopoiesisGEWIRTZ, A. M; HOFFMAN, R.British journal of haematology. 1986, Vol 62, Num 2, pp 333-344, issn 0007-1048Article

A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitroGEWIRTZ, A. M; CALABRETTA, B.Science (Washington, D.C.). 1988, Vol 242, Num 4883, pp 1303-1306, issn 0036-8075Article

Oncogenes, protooncogenes, and tumor suppressor genes in acute myelogenous leukemiaHIJIYA, N; GEWIRTZ, A. M.Journal of pediatric hematology/oncology. 1995, Vol 17, Num 2, pp 101-112, issn 1077-4114Article

Human megakaryocyte production : cell biology and clinical considerationsGEWIRTZ, A. M; HOFFMAN, R.Hematology/oncology clinics of North America. 1990, Vol 4, Num 1, pp 43-64, issn 0889-8588, 22 p.Article

Molecular regulation of human megakaryocyte developmentGEWIRTZ, A. M; CALABRETTA, B.International journal of cell cloning. 1990, Vol 8, Num 4, pp 267-276, issn 0737-1454, 10 p.Article

Does purging with antisense make sense ?GEWIRTZ, A. M.Bone marrow transplantation. Supplement (Basingstoke). 1995, Vol 15, Num 1, pp S314-S319, issn 0951-3078Conference Paper

The c-myb proto-oncogene : a novel target for human gene therapyGEWIRTZ, A. M.Cancer treatment and research. 1996, Vol 84, pp 93-112, issn 0927-3042Article

Megakaryocytopoiesis : the state of the artGEWIRTZ, A. M.Thrombosis and haemostasis. 1995, Vol 74, Num 1, pp 204-209, issn 0340-6245Conference Paper

An oligomer complementary to-c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell linesANFOSSI, G; GEWIRTZ, A. M; CALABRETTA, B et al.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 9, pp 3379-3383, issn 0027-8424Article

Human megakaryocytopoiesisSIMS, R. B; GEWIRTZ, A. M.Annual review of medicine. 1989, Vol 40, pp 213-224, issn 0066-4219Article

A functional analysis of protooncogene Vav's role in adult human hematopoiesisLUGER, S. M; RATAJCZAK, J; RATAJCZAK, M. Z et al.Blood. 1996, Vol 87, Num 4, pp 1326-1334, issn 0006-4971Article

Chemokine regulation of human megakaryocytopoiesisGEWIRTZ, A. M; JIN ZHANG; RATAJCZAK, J et al.Blood. 1995, Vol 86, Num 7, pp 2559-2567, issn 0006-4971Article

The biology of hematopoietic stem cellsRATAJCZAK, M. Z; GEWIRTZ, A. M.Seminars in oncology. 1995, Vol 22, Num 3, pp 210-217, issn 0093-7754Article

Cellular and molecular regulation of factor V expression in human megakaryocytesGEWIRTZ, A. M; SHAPIRO, C; YU MIN SHEN et al.Journal of cellular physiology. 1992, Vol 153, Num 2, pp 277-287, issn 0021-9541Article

Role of natural killer cells, in comparison with T lymphocytes and monocytes, in the regulation of normal human megakaryocytopoiesis in vitroGEWIRTZ, A. M; WEN YU XU; MANGAN, K. F et al.The Journal of immunology (1950). 1987, Vol 139, Num 9, pp 2915-2924, issn 0022-1767Article

Biology of human megakaryocyte factor VGEWIRTZ, A. M; KEEFER, M; DOSHI, K et al.Blood. 1986, Vol 67, Num 6, pp 1639-1648, issn 0006-4971Article

Cell-mediated suppression of megakaryocytopoiesis in acquired amegakaryocytic thrombocytopenic purpuraGEWIRTZ, A. M; SACCHETTI, M. K; BIEN, R et al.Blood. 1986, Vol 68, Num 3, pp 619-626, issn 0006-4971Article

Nucleic acid therapeutics : State of the art and future prospectsGEWIRTZ, A. M; SOKOL, D. L; RATAJCZAK, M. Z et al.Blood. 1998, Vol 92, Num 3, pp 712-736, issn 0006-4971Article

CD34+, kit+, rhodamine 123low phenotype identifies a marrow cell population highly enriched for human hematopoietic stem cellsRATAJCZAK, M. Z; PLETCHER, C. H; MARLICZ, W et al.Leukemia. 1998, Vol 12, Num 6, pp 942-950, issn 0887-6924Article

Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growthRATAJCZAK, M. Z; RATAJCZAK, J; MACHALINSKI, B et al.British journal of haematology. 1998, Vol 103, Num 4, pp 969-979, issn 0007-1048Article

Recombinant human thrombopoietin (TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosisRATAJCZAK, M. Z; RATAJCZAK, J; MALICZ, W et al.British journal of haematology. 1997, Vol 98, Num 1, pp 8-17, issn 0007-1048Article

Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cellsRATAJCZAK, M. Z; KUCZYNSKI, W. I; SOKOL, D. L et al.Blood. 1995, Vol 86, Num 6, pp 2161-2167, issn 0006-4971Article

  • Page / 3